Brief: Caribou Biosciences Reports Third Quarter 2022 Financial Results, Provides Business Update

Caribou Biosciences

08/11/2022 23:03

Nov 8 (Reuters) - Caribou Biosciences Inc  CRBU.O :
    * CARIBOU BIOSCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * CARIBOU BIOSCIENCES INC - FINANCIAL POSITION OF $342.6
MILLION
IN CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES AS OF
SEPTEMBER 30, 2022
    * CARIBOU BIOSCIENCES INC - CB-011 IND APPLICATION FOR R/R
MM
SUBMITTED TO FDA IN Q4 2022
    * CARIBOU BIOSCIENCES INC - CB-010 ANTLER PHASE 1 TRIAL IN
R/R
B-NHL ADVANCING; ADDITIONAL DATA FROM COHORT 1 EXPECTED BY YE
2022
    * CARIBOU BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.44

Source text for Eikon:  ID:nGNX56vmQ9 
Further company coverage:  CRBU.O 
 ((Reuters.Briefs@thomsonreuters.com;))